Skip to main content
. 2020 Jun 8;12:1758835920927838. doi: 10.1177/1758835920927838

Table 2.

Characteristics of the studies on disease-free survival outcomes of breast cancer patients according to cathepsin D status.

Author No. of patients
High CTSD/low CTSD
(Total patients)
Median follow-up (months) Survival analysis test Detection method Staining location Cut-off value (low/high level)
Granata et al.43 67/68 (135) 87 KM plot ELSA cytosol High (>40 pmol/mg)
Pujol et al.28 64/59 (123) 59 KM plot ELSA cytosol High (>20 pmol/mg)
Tetu et al.44 262/376 (638) 58 KM plot IHC cytosol High (stained 10%)
Ferno et al.45 184/70 (153) 37 KM plot ELSA cytosol High (>45 pmol/mg)
Donoghue et al.31 75/28 (103) 60 KM plot IHC stromal cell High (stained 25%)
Foekens et al.33 1405/1405 (2810) 88 KM plot ELSA cytosol High (>45.2 pmol/mg)
Jahkola et al.46 54/65 (119) 94 Univariate IHC stromal cell High (stained 10%)
Billgren et al.47 707/214 (921) 59 Univariate ELSA cytosol High (>10 pmol/mg)
Rodriguez et al.36 307/696 (1003) 54 KM plot ELSA cytosol High (>59 pmol/mg)
Jacobson et al.39 252/18 (270) 126 Univariate IHC cytosol High (> third quartile)
Chen et al.40 155/44 (199) 60 Univariate IHC cytosol High (stained 10%)
Markićević et al.48 39/19 (58) 18 KM plot ELSA cytosol High (>39 pmol/mg)
Tazhibi et al.49 637/38 (675) 59 KM plot IHC cytosol High (stained 20%)
Huang et al.41 140/45 (185) 66 Univariate IHC cytosol High (stained 20%)
Sun et al.50 91/64 (155) NA KM plot IHC cytosol High (stained 26%)

CTSD, cathepsin D; ELSA, immunoradiometric assay; IHC, immunohistochemistry; KM plot, Kaplan–Meier plot.